Cargando…

Clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infections in hospitalized patients and multi-surge comparison in Louisiana

BACKGROUND: Peer reviewed data describing SARS-CoV-2 Omicron variant symptoms and clinical outcomes as compared to prior surges in the United States is thus far limited. We sought to determine disease severity, presenting features, and epidemiologic factors of the SARS-CoV-2 Omicron variant compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Katie, Rivere, Evan, Jagneaux, Tonya, LeBoeuf, Gabrielle, Estela, Karen, Pierce, Christi, O’Neal, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586372/
https://www.ncbi.nlm.nih.gov/pubmed/36269696
http://dx.doi.org/10.1371/journal.pone.0268853
_version_ 1784813678771568640
author Taylor, Katie
Rivere, Evan
Jagneaux, Tonya
LeBoeuf, Gabrielle
Estela, Karen
Pierce, Christi
O’Neal, Catherine
author_facet Taylor, Katie
Rivere, Evan
Jagneaux, Tonya
LeBoeuf, Gabrielle
Estela, Karen
Pierce, Christi
O’Neal, Catherine
author_sort Taylor, Katie
collection PubMed
description BACKGROUND: Peer reviewed data describing SARS-CoV-2 Omicron variant symptoms and clinical outcomes as compared to prior surges in the United States is thus far limited. We sought to determine disease severity, presenting features, and epidemiologic factors of the SARS-CoV-2 Omicron variant compared to prior surges. METHODS: Retrospective cohort analysis was performed on patients admitted during five surges in Louisiana between March 2020 and January 2022. Patient data was pulled from the medical record and a subset of patients during Surge 5 were manually abstracted. Patients who were admitted to one of six Louisiana hospitals with a positive SARS-CoV-2 test during the 5 defined surge periods were included. Surges were compared using chi-squared tests and one way ANOVA for age, sex, vaccination status, length of stay, ICU status, ventilation requirement, and disposition at discharge. The records of patients admitted during the omicron surge were analyzed for presenting symptoms and incidental SARS-CoV-2 diagnosis. RESULTS: With each subsequent surge, a smaller proportion of patients presenting to the emergency department were admitted. Patients admitted during surge 5 had shorter lengths of stay and fewer comorbidities than prior surges. Fewer patients in surge 5 presented with a respiratory condition and fewer required ICU admission. In surges 4 and 5, fewer vaccinated patients were admitted compared to their unvaccinated counterparts. Overall mortality was lower in surge 5 (9%) than in surge 4 (15%) p < .0005. Of the SARS-Cov-2 admissions in surge 5, 22.3% were felt to be incidental diagnoses. CONCLUSIONS: As the COVID-19 pandemic progressed, a younger and less vaccinated population was associated with higher risk for severe disease, fewer patients required ICU admission and overall mortality decreased. Vaccinations seemed to be protective for overall risk of hospitalization but once admitted did not seem to confer additional protection against severe illness during the omicron surge. Age also contributed to patient outcomes.
format Online
Article
Text
id pubmed-9586372
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-95863722022-10-22 Clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infections in hospitalized patients and multi-surge comparison in Louisiana Taylor, Katie Rivere, Evan Jagneaux, Tonya LeBoeuf, Gabrielle Estela, Karen Pierce, Christi O’Neal, Catherine PLoS One Research Article BACKGROUND: Peer reviewed data describing SARS-CoV-2 Omicron variant symptoms and clinical outcomes as compared to prior surges in the United States is thus far limited. We sought to determine disease severity, presenting features, and epidemiologic factors of the SARS-CoV-2 Omicron variant compared to prior surges. METHODS: Retrospective cohort analysis was performed on patients admitted during five surges in Louisiana between March 2020 and January 2022. Patient data was pulled from the medical record and a subset of patients during Surge 5 were manually abstracted. Patients who were admitted to one of six Louisiana hospitals with a positive SARS-CoV-2 test during the 5 defined surge periods were included. Surges were compared using chi-squared tests and one way ANOVA for age, sex, vaccination status, length of stay, ICU status, ventilation requirement, and disposition at discharge. The records of patients admitted during the omicron surge were analyzed for presenting symptoms and incidental SARS-CoV-2 diagnosis. RESULTS: With each subsequent surge, a smaller proportion of patients presenting to the emergency department were admitted. Patients admitted during surge 5 had shorter lengths of stay and fewer comorbidities than prior surges. Fewer patients in surge 5 presented with a respiratory condition and fewer required ICU admission. In surges 4 and 5, fewer vaccinated patients were admitted compared to their unvaccinated counterparts. Overall mortality was lower in surge 5 (9%) than in surge 4 (15%) p < .0005. Of the SARS-Cov-2 admissions in surge 5, 22.3% were felt to be incidental diagnoses. CONCLUSIONS: As the COVID-19 pandemic progressed, a younger and less vaccinated population was associated with higher risk for severe disease, fewer patients required ICU admission and overall mortality decreased. Vaccinations seemed to be protective for overall risk of hospitalization but once admitted did not seem to confer additional protection against severe illness during the omicron surge. Age also contributed to patient outcomes. Public Library of Science 2022-10-21 /pmc/articles/PMC9586372/ /pubmed/36269696 http://dx.doi.org/10.1371/journal.pone.0268853 Text en © 2022 Taylor et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Taylor, Katie
Rivere, Evan
Jagneaux, Tonya
LeBoeuf, Gabrielle
Estela, Karen
Pierce, Christi
O’Neal, Catherine
Clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infections in hospitalized patients and multi-surge comparison in Louisiana
title Clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infections in hospitalized patients and multi-surge comparison in Louisiana
title_full Clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infections in hospitalized patients and multi-surge comparison in Louisiana
title_fullStr Clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infections in hospitalized patients and multi-surge comparison in Louisiana
title_full_unstemmed Clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infections in hospitalized patients and multi-surge comparison in Louisiana
title_short Clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infections in hospitalized patients and multi-surge comparison in Louisiana
title_sort clinical characteristics and outcomes of sars-cov-2 b.1.1.529 infections in hospitalized patients and multi-surge comparison in louisiana
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586372/
https://www.ncbi.nlm.nih.gov/pubmed/36269696
http://dx.doi.org/10.1371/journal.pone.0268853
work_keys_str_mv AT taylorkatie clinicalcharacteristicsandoutcomesofsarscov2b11529infectionsinhospitalizedpatientsandmultisurgecomparisoninlouisiana
AT rivereevan clinicalcharacteristicsandoutcomesofsarscov2b11529infectionsinhospitalizedpatientsandmultisurgecomparisoninlouisiana
AT jagneauxtonya clinicalcharacteristicsandoutcomesofsarscov2b11529infectionsinhospitalizedpatientsandmultisurgecomparisoninlouisiana
AT leboeufgabrielle clinicalcharacteristicsandoutcomesofsarscov2b11529infectionsinhospitalizedpatientsandmultisurgecomparisoninlouisiana
AT estelakaren clinicalcharacteristicsandoutcomesofsarscov2b11529infectionsinhospitalizedpatientsandmultisurgecomparisoninlouisiana
AT piercechristi clinicalcharacteristicsandoutcomesofsarscov2b11529infectionsinhospitalizedpatientsandmultisurgecomparisoninlouisiana
AT onealcatherine clinicalcharacteristicsandoutcomesofsarscov2b11529infectionsinhospitalizedpatientsandmultisurgecomparisoninlouisiana